- Home
- MLYS vs TREE Comparison
MLYS vs TREE Comparison
Compare MLYS & TREE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- TREE
- Stock Information
- Founded
- MLYS 2019
- TREE 1996
- Country
- MLYS United States
- TREE United States
- Employees
- MLYS N/A
- TREE N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- TREE Finance: Consumer Services
- Sector
- MLYS Health Care
- TREE Finance
- Exchange
- MLYS Nasdaq
- TREE Nasdaq
- Market Cap
- MLYS 890.6M
- TREE 978.1M
- IPO Year
- MLYS 2023
- TREE N/A
- Fundamental
- Price
- MLYS $37.16
- TREE $71.77
- Analyst Decision
- MLYS Strong Buy
- TREE Buy
- Analyst Count
- MLYS 6
- TREE 8
- Target Price
- MLYS $42.60
- TREE $65.38
- AVG Volume (30 Days)
- MLYS 2.6M
- TREE 284.7K
- Earning Date
- MLYS 11-10-2025
- TREE 10-30-2025
- Dividend Yield
- MLYS N/A
- TREE N/A
- EPS Growth
- MLYS N/A
- TREE N/A
- EPS
- MLYS N/A
- TREE N/A
- Revenue
- MLYS N/A
- TREE $1,012,155,000.00
- Revenue This Year
- MLYS N/A
- TREE $17.19
- Revenue Next Year
- MLYS N/A
- TREE $7.58
- P/E Ratio
- MLYS N/A
- TREE N/A
- Revenue Growth
- MLYS N/A
- TREE 51.65
- 52 Week Low
- MLYS $8.24
- TREE $33.50
- 52 Week High
- MLYS $39.20
- TREE $74.15
- Technical
- Relative Strength Index (RSI)
- MLYS 86.84
- TREE 73.09
- Support Level
- MLYS $35.00
- TREE $70.72
- Resistance Level
- MLYS $15.79
- TREE $74.15
- Average True Range (ATR)
- MLYS 2.50
- TREE 2.43
- MACD
- MLYS 2.05
- TREE -0.37
- Stochastic Oscillator
- MLYS 91.73
- TREE 78.99
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.